Top section
Top section
Adnoc expands sustainable financing with $2bn green loan
The company's new loan is backed by a Korean export credit agency
By backing too many speculative IPOs, investment banks could threaten the whole market
Finland's YIT signs €200m SLL and amends term loan
Company retains same roster of banks that provided last loan
By backing too many speculative IPOs, investment banks could threaten the whole market
Sub-sections
-
With Latin America bond issuance smashing through its previous record, market participants think the peak has passed. A market tipped to turn tougher is the reason, which will make 2026 a year when issuers and bankers will have to earn every basis point, writes George Collard, with volumes expected to stay high -
Falling interest rates, returning inflows and a wave of pandemic-era redemptions mean CEEMEA bond market participants have high expectations for 2026. This optimism comes after a record-breaking year for issuance — and by quite some margin — meaning that 2025 will be a tough act to follow, writes George Collard
-
A booming 2025 investment grade corporate bond market in Europe set a high bar as investors brace to pay higher premiums and shift to the belly of the curve in 2026. Meanwhile, capex, M&A and Reverse Yankees look set to keep the pipeline full, write Diana Bui and Frank Jackman
-
The European FIG market rode through 2025 on high demand for credit, providing bank issuers, large and small, with extremely advantageous funding conditions. Although investors have also benefitted from strong secondary market performance, as Atanas Dinov reports, that equilibrium may change in 2026, with anticipation mounting that spreads will widen
-
The CEEMEA primary bond market in 2025 shattered the record for bond issuance by some distance. Investors flocked to buy ahead of US interest rate cuts, meaning the market was open to just about every issuer. It is hard to find too many deals that were not a success, making this the pick of a very large crop
-
Investment grade companies demonstrated just how much liquidity was sloshing around in the euro, dollar, sterling and Swiss franc markets with a string of large deals. But these bonds did not just stand out for the amount issued. Rather, they showed that there is not always a trade-off to be made between size and price
-
Bank's head of DCM and syndicate chief talk bond market expansion plans
-
Loans bankers wary of potential overbuilding amid Europe data centre growth
-
Scope of UK regulation set to be more restricted than EU equivalent
-
German government will spend €108bn on military next year
-
Taxonomy alignment and credible transition plans could be more important for issuers
-
First-of-its-kind opinion lays out World Bank, ADB and shareholders’ obligations under international law
-
First exclusively Estonian securitization the European Investment Bank has supported
-
Debt financing to become more sophisticated as the race to build data centres across Europe heats up
-
JP Morgan sole bookrunner on first jumbo block in a month
-
This week Tom Hall and Thomas Hopkins discuss how Enpal's return heated up the ABS market and take the CLO equity market's temperature
-
Company's relationship banks provided the funding
-
UK chancellor got the big things right in the Budget but made damaging unforced errors
-
Artificial intelligence is everywhere — but what is it doing? Capital market specialists think about it constantly, even if only because they are told to, with feelings ranging from delight to horror. Market participants are exploring myriad ways both to use AI, writes Jon Hay, and neutralise its risks
-
December is a strange time to be in the capital markets. Embrace it
-
This week a managing director deals with the awkwardness of their boss finding out they had been in contention for a job at another firm
-
Zylox-Tonbridge Medical Technology, a China-based medical device maker, is looking to raise up to HK$2.56bn ($329.9m) from a Hong Kong IPO.
-
General Atlantic-owned Indian healthcare group Krishna Institute of Medical Sciences (Kims) has raised around Rp21.4bn ($288m) from a nearly four times subscribed IPO.
-
Biopharmaceutical company HutchMed (China) kicked off the roadshow for its HK$4.68bn ($602.7m) Hong Kong IPO on Friday, placing more than half of the shares in its third listing with cornerstone investors.
-
Sponsored by Islamic Development Bank (IsDB)
Sukuk market’s next chapter: Financing the future, sustainably
-
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
